Related Experiment Video

Updated: Jul 14, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

[High doses of botulinum toxin type A in children: efficacy and safety in clinical practice]

P Filipetti1, F Chantraine

  • 1Unité d'Analyse Quantifiée du Mouvement, Centre National de Rééducation Fonctionnelle et de Réadaptiation, 2, Rue Englebert Neveu, L-2224 Luxembourg, Luxembourg. filipetti.paul@hotmail.f

Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique
|June 15, 2007
PubMed

Insights

High doses of botulinum toxin type A offer a safe and effective treatment for multifocal cerebral palsy (CP) spasticity in children. This approach, when integrated with other therapies, shows no increased complications, warranting further long-term studies.

Area of Science:

  • Neurology
  • Pediatrics
  • Rehabilitation Medicine

Context:

  • Childhood spasticity, particularly in Cerebral Palsy (CP), presents complex management challenges.
  • Early intervention and understanding neurological maturation are crucial for effective treatment.
  • Identifying specific gait patterns aids in selecting appropriate target muscles for intervention.

Purpose:

  • To review the current administration of high-dose botulinum toxin type A for pediatric spasticity.
  • To explore the relationship between CP neurological development and early management strategies.
  • To assess the safety and efficacy of higher botulinum toxin A doses in CP.

Summary:

  • High-dose botulinum toxin type A is a safe and effective treatment for multifocal CP spasticity when part of an integrated management plan.
  • Literature review indicates that dose adaptation is key, with no evidence of increased complications from higher doses.
  • Further research is recommended to evaluate the long-term safety and efficacy of this therapeutic approach in children with CP.

Impact:

  • Provides clinicians with guidance on adapting botulinum toxin A dosages for pediatric CP.
  • Supports the use of high-dose botulinum toxin A as a viable component of comprehensive CP management.
  • Highlights the need for ongoing research into long-term outcomes of this treatment modality.

More Related Videos

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...